Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G de Groot

Showing results (301-310 of 778) with videos related to

Pageof 78
Sort By:
The Journal of Clinical Investigation|July 1, 1993
Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteinsF R Agbanyo, J J Sixma, P G de Groot, et al.
The Journal of Hand Surgery|November 1, 1985
Lunate implant resection arthroplasty: long-term resultsA B Swanson, B K Maupin, G de Groot Swanson, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1983
A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified componentsK S Sakariassen, P A Aarts, P G de Groot, et al.
Thrombosis and Haemostasis|December 8, 1998
The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodiesD A Horbach, E van Oort, M J Tempelman, et al.
Lupus|November 14, 1998
Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulantP G de Groot, D A Horbach, M J Simmelink, et al.
Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'R T Urbanus, M T T Pennings, R H W M Derksen, et al.
Plos Medicine|May 9, 2008
Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosisMirjam E Meltzer, Ton Lisman, Carine J M Doggen, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1991
Differences in the duration of sedative and anxiolytic effects of desmethyldiazepam in two outbred Wistar strainsJ W van der Laan, S F de Boer, J van der Gugten, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2010
Thrombin-activatable fibrinolysis inhibitor is degraded by Salmonella enterica and Yersinia pestisM Valls Serón, J Haiko, P G DE Groot, et al.
Medicine and Science in Sports and Exercise|December 1, 1995
The start in speed skating: from running to glidingJ J de Koning, R Thomas, M Berger, et al.
Pageof 78

Showing results (301-310 of 778) with videos related to

Sort By:
Pageof 78
The Journal of Clinical Investigation|July 1, 1993
Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteinsF R Agbanyo, J J Sixma, P G de Groot, et al.
The Journal of Hand Surgery|November 1, 1985
Lunate implant resection arthroplasty: long-term resultsA B Swanson, B K Maupin, G de Groot Swanson, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1983
A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified componentsK S Sakariassen, P A Aarts, P G de Groot, et al.
Thrombosis and Haemostasis|December 8, 1998
The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodiesD A Horbach, E van Oort, M J Tempelman, et al.
Lupus|November 14, 1998
Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulantP G de Groot, D A Horbach, M J Simmelink, et al.
Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'R T Urbanus, M T T Pennings, R H W M Derksen, et al.
Plos Medicine|May 9, 2008
Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosisMirjam E Meltzer, Ton Lisman, Carine J M Doggen, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1991
Differences in the duration of sedative and anxiolytic effects of desmethyldiazepam in two outbred Wistar strainsJ W van der Laan, S F de Boer, J van der Gugten, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2010
Thrombin-activatable fibrinolysis inhibitor is degraded by Salmonella enterica and Yersinia pestisM Valls Serón, J Haiko, P G DE Groot, et al.
Medicine and Science in Sports and Exercise|December 1, 1995
The start in speed skating: from running to glidingJ J de Koning, R Thomas, M Berger, et al.
Pageof 78